STAAR Surgical Company (FRA:SR3)

Germany flag Germany · Delayed Price · Currency is EUR
22.71
+0.21 (0.93%)
At close: Dec 5, 2025
-9.77%
Market Cap 1.09B
Revenue (ttm) 197.20M
Net Income (ttm) -82.41M
Shares Out n/a
EPS (ttm) -1.67
PE Ratio n/a
Forward PE 55.66
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 25
Open 22.71
Previous Close 22.50
Day's Range 22.71 - 22.71
52-Week Range 12.79 - 25.06
Beta n/a
RSI 50.40
Earnings Date Feb 17, 2026

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors... [Read more]

Industry Ophthalmic Goods
Founded 1982
Employees 1,157
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol SR3
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.